ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pearl, J. M.
Right arrow Articles by Chang, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pearl, J. M.
Right arrow Articles by Chang, P. A.

The Annals of Thoracic Surgery, Vol 57, 1636-1641, Copyright © 1994 by The Society of Thoracic Surgeons


ARTICLES

Fumarate-enriched blood cardioplegia results in complete functional recovery of immature myocardium

JM Pearl, J Hiramoto, H Laks, DC Drinkwater Jr and PA Chang
Department of Surgery, University of California at Los Angeles Medical Center 90024.

Amino acid enrichment of cardioplegic solutions has been shown to improve both the metabolic and functional recovery of ischemic myocardium. However, because of the marked systemic vasodilatation involved, use of amino acid enrichment is limited to the periods of induction and reperfusion. Fumarate is a Krebs' cycle intermediate whose conversion to succinate is responsible for the generation of adenosone triphosphate and the oxidation of the reduced form of nicotinamide-adenine nucleotide which is the pathway by which aspartate exerts its effect. Fumarate may also function as a free-radical scavenger and is involved in calcium transport. To determine if fumarate-enriched blood cardioplegia would improve the functional recovery of the neonatal heart, 14 neonatal piglet hearts were isolated and placed on a blood-perfused working heart circuit. After the baseline functional and metabolic assessment was done, cold ischemic arrest was initiated with either standard blood cardioplegic solution (group I; N = 7) or fumarate-enriched (13 mmol/L) blood cardioplegic solution (group II; N = 7). Cardioplegic solution was given at a pressure of 40 mm Hg every 20 minutes for 2 hours, and topical hypothermia was used. Sixty minutes after warm whole blood reperfusion, the functional recovery at left atrial pressures of 3, 6, 9, and 12 mm Hg was 70%, 66%, 66%, and 65%, respectively, in group I, versus 102%, 106%, 105%, and 109%, respectively, in group II (p < 0.05). The tissue creatinine phosphate levels after reperfusion were significantly higher in group II hearts (15.0 +/- 1.2 mumol/g dry heart tissue) than in group I hearts (9.2 +/- 1.9 mumol/g dry heart tissue), although the adenosine triphosphate levels were not significantly different.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
T. Doenst, C. Schlensak, and F. Beyersdorf
Cardioplegia in pediatric cardiac surgery: do we believe in magic?
Ann. Thorac. Surg., May 1, 2003; 75(5): 1668 - 1677.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. D. Hardin, G. Lazzarino, B. Tavazzi, D. Di Pierro, T. M. Roberts, B. Giardina, and M. J. Rovetto
Myocardial metabolism of exogenous FDP is consistent with transport by a dicarboxylate transporter
Am J Physiol Heart Circ Physiol, December 1, 2001; 281(6): H2654 - H2660.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. M. Weinberg, M. A. Venkatachalam, N. F. Roeser, P. Saikumar, Z. Dong, R. A. Senter, and I. Nissim
Anaerobic and aerobic pathways for salvage of proximal tubules from hypoxia-induced mitochondrial injury
Am J Physiol Renal Physiol, November 1, 2000; 279(5): F927 - F943.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. T. Kronon, B. S. Allen, K. S. Bolling, S. Rahman, T. Wang, H. S. Maniar, S. M. Prasad, and M. N. Ilbawi
The role of cardioplegia induction temperature and amino acid enrichment in neonatal myocardial protection
Ann. Thorac. Surg., September 1, 2000; 70(3): 756 - 764.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
J. Martin, K. Sarai, M. Yoshitake, J. Haberstroh, N. Takahashi, G. Lutter, and F. Beyersdorf
Orthotopic transplantation of pig hearts harvested after 30 min of normothermic ischemia: controlled reperfusion with blood cardioplegia containing the Na+-H+-exchange inhibitor HOE 642
Eur. J. Cardiothorac. Surg., December 1, 1998; 14(6): 607 - 614.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Chandra
Reanimation and engraftment of the asystolic primate heart
J. Thorac. Cardiovasc. Surg., March 1, 1996; 111(3): 684 - 684.
[Full Text]


Home page
Ann. Thorac. Surg.Home page
E. R. Rosenkranz
Substrate Enhancement of Cardioplegic Solution: Experimental Studies and Clinical Evaluation
Ann. Thorac. Surg., September 1, 1995; 60(3): 797 - 800.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1994 by The Society of Thoracic Surgeons.